{"pageContent": "Purpose: Partial gland ablation (PGA) using high-intensity focused ultrasound (HIFU) is currently under investigation for clinically significant prostate cancer (Cs-PCa). Our primary objective was to assess the role of systematic control biopsies following HIFU-PGA in a cohort of Cs-PCa patients.", "metaData": {"source": "[Treatment of localized prostate cancer]\nhttps://pubmed.ncbi.nlm.nih.gov/19238791/"}}